バイオインフォマティクスサービスの世界市場：タイプ別、用途別、専門分野別、エンドユーザー別、地域別、機会、予測、2018年～2032年

世界のバイオインフォマティクスサービスの市場規模は、2025年～2032年の予測期間中に15.39％のCAGRで拡大し、2024年の34億4,000万米ドルから2032年には108億2,000万米ドルに成長すると予測されています。同市場の成長は、幅広い産業でバイオインフォマティクスに対する要求が高まっていること、プロテオミクスとゲノミクスに対する要求が高まっていること、公的・民間資金が増加していること、バイオインフォマティクス・サービスの効率性とアクセシビリティを高めるユーザーフレンドリーなバイオインフォマティクス・ソフトウェアとツールの開発が進んでいることなどが背景にあります。精密ヘルスケアと医療への注目の高まりも、様々な疾患の様々な危険因子の発見、個人の遺伝子データに基づく治療アプローチの個別化、治療アプローチの個別化を可能にする様々なバイオインフォマティクス・ソリューションとサービスへの需要を増大させています。質量分析や次世代シーケンシングなどの先端技術の登場により、生成される生物学的データ量が飛躍的に増加したため、データの保存、分析、解釈のための高度なサービスへの需要が高まっています。

さらに、技術革新への注目の高まりと、さまざまな作業の効果的で正確な分析を促進する新しいバイオインフォマティクス・ツールの導入も、バイオインフォマティクス・サービス市場の成長を後押ししています。例えば、2024年5月、ライフサイエンス業界向けの複雑なデータ解析のための主要なソフトウェアプロバイダーの1つであるSequeraは、簡素化されたバイオインフォマティクス・コンテナ・ソリューションであるSequera Containersを発表し、研究者や開発者がカスタムのコンテナイメージをアップロードしたり構築したりすることなく、要件に合わせたさまざまなコンテナを簡単に組み立てることができるよう支援しました。このソリューションの支援により、同社は科学者のさまざまな分析要件のための集中ハブを作成し、調査方法のペースを加速するために科学コミュニティにアクセスを提供することによって、科学者をサポートすることができます。

慢性疾患の蔓延による製薬・バイオテクノロジー業界への負担の増大は、研究活動を促進し、新薬や診断ソリューションの開発を促進し、精密医療の開発をサポートするバイオインフォマティクス・サービスへの依存度を高めています。さらに、機械学習と人工知能をさまざまなバイオインフォマティクス・ツールと統合する取り組みが活発化していることも、この統合によってデータ分析が強化され、その精度が向上し、時間効率の高い方法で新薬の開発につながることから、市場の需要を増大させています。クラウドベースのバイオインフォマティクス・ソリューションとゲノム研究を支援する政府のイニシアチブの増加とともに、研究開発への投資が増加していることも、市場の拡大を後押しする主な要因です。

当レポートでは、世界のバイオインフォマティクスサービス市場について調査し、市場の概要とともに、タイプ別、用途別、専門分野別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のバイオインフォマティクスサービス市場の見通し、2018年～2032年

• 市場規模の分析と予測
• 市場シェア分析と予測
• 市場マップ分析、2024年
  • タイプ別
  • 用途別
  • 専門分野別
  • エンドユーザー別
  • 地域別

第5章 北米のバイオインフォマティクスサービス市場の見通し、2018年～2032年

第6章 欧州のバイオインフォマティクスサービス市場の見通し、2018年～2032年

第7章 アジア太平洋のバイオインフォマティクスサービス市場の見通し、2018年～2032年

第8章 南米のバイオインフォマティクスサービス市場の見通し、2018年～2032年

第9章 中東・アフリカのバイオインフォマティクスサービス市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 ポーターのファイブフォース分析

第12章 PESTLE分析

第13章 価格分析

第14章 市場力学

第15章 市場の動向と発展

第16章 規制枠組みとイノベーション

第17章 特許の情勢

第18章 ケーススタディ

第19章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 主要企業トップ5のSWOT分析
• 主要企業トップ10の情勢
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • CD Genomics
  • PerkinElmer AES
  • Fios Genomics Ltd
  • QIAGEN N.V.
  • Source BioScience Limited
  • Biomax GmbH
  • Illumina, Inc.
  • BGI Group

第20章 戦略的提言

第21章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 2. Global Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 3. Global Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 4. Global Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 5. Global Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 6. Global Bioinformatics Services Market Share (%), By Region, 2018-2032F
• Figure 7. North America Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 8. North America Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 9. North America Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 10. North America Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 11. North America Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 12. North America Bioinformatics Services Market Share (%), By Country, 2018-2032F
• Figure 13. United States Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 14. United States Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 15. United States Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 16. United States Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 17. United States Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 18. Canada Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 19. Canada Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 20. Canada Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 21. Canada Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 22. Canada Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 23. Mexico Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 24. Mexico Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 25. Mexico Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 26. Mexico Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 27. Mexico Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 28. Europe Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 29. Europe Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 30. Europe Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 31. Europe Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 32. Europe Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 33. Europe Bioinformatics Services Market Share (%), By Country, 2018-2032F
• Figure 34. Germany Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 35. Germany Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 36. Germany Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 37. Germany Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 38. Germany Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 39. France Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 40. France Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 41. France Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 42. France Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 43. France Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 44. Italy Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 45. Italy Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 46. Italy Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 47. Italy Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 48. Italy Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 49. United Kingdom Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 50. United Kingdom Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 51. United Kingdom Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 52. United Kingdom Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 53. United Kingdom Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 54. Russia Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 55. Russia Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 56. Russia Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 57. Russia Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 58. Russia Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 59. Netherlands Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 60. Netherlands Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 61. Netherlands Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 62. Netherlands Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 63. Netherlands Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 64. Spain Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 65. Spain Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 66. Spain Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 67. Spain Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 68. Spain Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 69. Turkey Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 70. Turkey Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 71. Turkey Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 72. Turkey Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 73. Turkey Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 74. Poland Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 75. Poland Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 76. Poland Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 77. Poland Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 78. Poland Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 79. South America Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 80. South America Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 81. South America Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 82. South America Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 83. South America Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 84. South America Bioinformatics Services Market Share (%), By Country, 2018-2032F
• Figure 85. Brazil Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 86. Brazil Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 87. Brazil Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 88. Brazil Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 89. Brazil Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 90. Argentina Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 91. Argentina Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 92. Argentina Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 93. Argentina Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 94. Argentina Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 95. Asia-Pacific Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 96. Asia-Pacific Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 97. Asia-Pacific Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 98. Asia-Pacific Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 99. Asia-Pacific Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 100. Asia-Pacific Bioinformatics Services Market Share (%), By Country, 2018-2032F
• Figure 101. India Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 102. India Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 103. India Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 104. India Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 105. India Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 106. China Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 107. China Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 108. China Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 109. China Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 110. China Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 111. Japan Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 112. Japan Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 113. Japan Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 114. Japan Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 115. Japan Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 116. Australia Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 117. Australia Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 118. Australia Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 119. Australia Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 120. Australia Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 121. Vietnam Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 122. Vietnam Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 123. Vietnam Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 124. Vietnam Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 125. Vietnam Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 126. South Korea Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 127. South Korea Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 128. South Korea Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 129. South Korea Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 130. South Korea Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 131. Indonesia Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 132. Indonesia Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 133. Indonesia Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 134. Indonesia Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 135. Indonesia Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 136. Philippines Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 137. Philippines Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 138. Philippines Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 139. Philippines Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 140. Philippines Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 141. Middle East & Africa Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 142. Middle East & Africa Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 143. Middle East & Africa Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 144. Middle East & Africa Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 145. Middle East & Africa Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 146. Middle East & Africa Bioinformatics Services Market Share (%), By Country, 2018-2032F
• Figure 147. Saudi Arabia Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 148. Saudi Arabia Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 149. Saudi Arabia Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 150. Saudi Arabia Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 151. Saudi Arabia Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 152. UAE Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 153. UAE Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 154. UAE Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 155. UAE Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 156. UAE Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 157. South Africa Bioinformatics Services Market, By Value, In USD Billion, 2018-2032F
• Figure 158. South Africa Bioinformatics Services Market Share (%), By Type, 2018-2032F
• Figure 159. South Africa Bioinformatics Services Market Share (%), By Application, 2018-2032F
• Figure 160. South Africa Bioinformatics Services Market Share (%), By Specialty, 2018-2032F
• Figure 161. South Africa Bioinformatics Services Market Share (%), By End-user, 2018-2032F
• Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 164. By Specialty Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Global bioinformatics services market is projected to witness a CAGR of 15.39% during the forecast period 2025-2032, growing from USD 3.44 billion in 2024 to USD 10.82 billion in 2032. The market's growth is augmented by the rising requirement for bioinformatics across a wide range of industries, increasing requirement for proteomics and genomics, growing public and private funding, and rising development of user-friendly bioinformatics software and tools that are increasing the efficiency and accessibility of bioinformatics services. The growing focus on precision healthcare and medicine is also augmenting the demand for various bioinformatics solutions and services to allow the discovery of various risk factors for different diseases, personalize therapeutic approaches on the basis of individual genetic data, and personalize therapeutic approaches. The advent of advanced technologies such as mass spectrometry and next-generation sequencing has resulted in an exponential increase in the volume of biological data that is being generated, thus bolstering the requirement for sophisticated services for storage, analysis, and interpretation of data.

Additionally, increasing focus on technological innovation and introduction of new bioinformatics tools that facilitate effective and accurate analysis of different tasks is also propelling the growth of the bioinformatics services market. For instance, in May 2024, Seqera, one of the leading software providers for complex data analysis for the life science industry, launched Seqera Containers, a streamlined bioinformatics container solution to create simplified experience and aid researchers and developers in effortlessly assembling different containers that are tailored to their requirements without uploading and building custom container images. With the help of this solution, the company is able to create a centralized hub for the different analytical requirements of scientists and support them by providing access to the scientific community to accelerate the pace of research processes.

The growing burden on pharmaceutical and biotechnology industries due to the rising prevalence of chronic diseases is augmenting the reliance on bioinformatics services to foster research activities, increase the development of novel drugs, diagnostic solutions, and support the development of precision medicine. Moreover, the rising efforts to increase the integration of machine learning and artificial intelligence with different bioinformatics tools are also augmenting the market's demand as this integration enhances data analysis and improves its accuracy, resulting in the development of new drugs in a time efficient manner. Rising investments in research and development along with increasing government initiatives that support cloud-based bioinformatics solutions and genomics research are other major factors fueling the market's expansion.

Innovation and Launch of New Services Support Market Expansion

Leading biotechnology services providing companies are increasingly investing in providing novel services and technologies including whole genome sequencing services for clinical and academic applications as well as for biotechnology and pharmaceutical companies. The rapid accumulation of vast amounts of biological data is propelling the requirement for advanced bioinformatics services for analyzing and interpreting complex biological data for creating new medications and tailored medical solutions. Thus, various bioinformatics companies are increasingly focusing on providing new technologies and services to their clients. For instance, in August 2024, Inocras Inc., started offering whole genome sequencing services with the help of the UG 100 sequencer, provided by Ultima Genomics, Inc. This collaborative effort of the two companies is expected to bolster the availability of affordable genomic solutions, facilitating wider adoption of bioinformatics and providing lucrative growth opportunities for the market.

Increasing Focus on Bioinformatics by Research Institutions Boosts Market Demand

The growing emphasis on bioinformatics research due to the rising requirement for the technique across a wide range of fields is propelling the demand for bioinformatics services. Various research and academic institutions are increasingly focused on launching bioinformatics centers to provide personalized medicines for a wide range of chronic diseases, further augmenting the growth of the global bioinformatics services market. For instance, in June 2024, the Washington University School of Medicine in St. Louis, Missouri, United States, formed a Center for Translational Bioinformatics to accelerate translational research that improves patient care by integrating expansive genomic and patient data. The center combines clinical data analysis with genomic research and supports the creation of technology platforms that bridge the gap between genetic, clinical, and research datasets. Such efforts of leading research institutions to augment bioinformatics science are expected to attract new investments and foster innovation, propelling the market's expansion and providing lucrative growth opportunities.

Drug Discovery Services Hold Significant Share of the Market

The dominance of drug discovery services can be attributed to the essential nature of bioinformatics tools and services for streamlining and accelerating the drug development process. Bioinformatics services aid drug developers in identifying potential drug targets, predicting drug interactions, and understanding complex disease mechanisms. Additionally, the rising requirement for precision medicines from various regions across the globe, along with increasing complexities of drug development processes, are also driving the requirement for bioinformatics services in drug discovery processes.

In order to ensure the availability of bioinformatics solutions for drug discovery applications, leading biotechnology companies across the globe are increasingly investing investments in providing customized solutions for the biopharmaceutical industry. For instance, in June 2024, Cyrus Biotechnology, Inc., a software-enabled biotechnology company, spun out a software and services group, Levitate Bio LLC, to bring Cyrus to the pharmaceutical sector. By providing a full stack of services and software, Levitate addresses the evolving requirements of the pharmaceutical industry, allowing the discovery of new drugs and expanding the capabilities of bioinformatics services in the pharmaceutical sector.

North America Region Holds Major Market Share

The market's rapid expansion in North America can be attributed to the strong presence of various companies focusing on proteomics and genomic technologies, the availability of enhanced infrastructure for life science and biotechnology research, and continuous investments in research and development activities. Additionally, the increasing efforts of educational institutions to introduce bioinformatics and artificial intelligence in the curriculum and prepare the students for the workforce by providing them with hands-on training are also driving innovations across the industry. For instance, in September 2024, Conectado Inc., one of the leading providers of immersive educational services, partnered with Hollister High School in California, United States, to provide specialized bootcamps in bioinformatics and artificial intelligence for the students. The bootcamps feature hands-on training on practical applications of bioinformatics and artificial intelligence and provide students with information about future career options in bioinformatics. Such efforts are bolstering awareness about the potential career opportunities in the bioinformatics sector and are expected to provide lucrative growth opportunities for the bioinformatics services market.

Future Market Scenario (2025 - 2032F)

As per the global bioinformatics services market analysis, the market is anticipated to witness lucrative growth opportunities over the coming years due to the increasing applications of bioinformatics in multiple industries, rising investments towards research and development activities, and technological advancements and innovations. The growing reliance on efficient data management and analysis tools coupled with the increasing focus on precision medicine are also expected to augment the reliance on bioinformatics services.

Cloud-based bioinformatics services are expected to gain traction in the coming years due to various advantages associated with these services including easy scalability and collaborative research, economic-efficiency, and increasing investments in cloud-based tools and services.

Additionally, increasing investments in the biotechnology industry due to the increasing applications of the technology across a broad range of fields coupled with rising collaborations and partnerships among leading research institutions and biotech companies to enhance bioinformatics solutions and services are also expected to foster innovation, positively influencing the market's expansion.

Key Players Landscape and Outlook

The key players in the market are actively engaging in mergers and acquisitions and partnerships to expand their global presence and provide end-to-end bioinformatics services. For instance, in November 2024, Solis Agrosciences Inc. acquired genomics platform of Ferris Genomics Inc., allowing Solis to provide end-to-end genomic services to agricultural customers. This acquisition is expected to allow Solis to expand its customer base and identify Ferris's technologies for identifying targets for leveraging genome and plant editing platforms to create new traits. Such acquisitions aim to create synergistic opportunities, providing lucrative growth opportunities for the market by offering integrated solutions to meet the evolving requirements of the plant biotechnology sector.

Similarly in April 2024, Strand Life Sciences Private Limited (a Reliance Industries Limited Subsidiary) partnered with SOPHiA GENETICS SA to deliver advanced solutions for augmenting the utilization of precision medicine across the globe. This partnership is focusing on strategic test development, among other initiatives for improving healthcare outcomes in different regions across the globe, including India. By combining their expertise, the companies are strengthening their position in the market. Such partnerships are bolstering the availability of tools and technologies that aid in accurate analysis of data, thus, positively influencing the expansion of the market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bioinformatics Services Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Sequencing Services
      • 4.2.1.1.1. Exome Analysis
      • 4.2.1.1.2. Transcriptome Analysis
      • 4.2.1.1.3. Metagenomic Analysis
      • 4.2.1.1.4. Other Services
    • 4.2.1.2. Data Analysis
      • 4.2.1.2.1. Genomic Data Analysis
      • 4.2.1.2.2. Proteomic Data Analysis
      • 4.2.1.2.3. Variant Data Analysis
    • 4.2.1.3. Drug Discovery Services
    • 4.2.1.4. Differential Gene Expression Analysis
    • 4.2.1.5. Database Management Services
    • 4.2.1.6. Others
  • 4.2.2. By Application
    • 4.2.2.1. Genomics
    • 4.2.2.2. Proteomics
    • 4.2.2.3. Chemoinformatics and Drug Design
    • 4.2.2.4. Pharmacogenomics
    • 4.2.2.5. Transcriptomics
    • 4.2.2.6. Metabolomics
    • 4.2.2.7. Others
  • 4.2.3. By Specialty
    • 4.2.3.1. Medical Biotechnology
    • 4.2.3.2. Animal Biotechnology
    • 4.2.3.3. Forensic Biotechnology
    • 4.2.3.4. Plant Biotechnology
    • 4.2.3.5. Environmental Biotechnology
  • 4.2.4. By End-user
    • 4.2.4.1. Academic Institutes and Research Centers
    • 4.2.4.2. Hospitals and Clinics
    • 4.2.4.3. Pharmaceutical and Biotechnology Companies
    • 4.2.4.4. Contract Research Organizations (CROs)
    • 4.2.4.5. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By Specialty
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Bioinformatics Services Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Type
    • 5.2.1.1. Sequencing Services
      • 5.2.1.1.1. Exome Analysis
      • 5.2.1.1.2. Transcriptome Analysis
      • 5.2.1.1.3. Metagenomic Analysis
      • 5.2.1.1.4. Other Services
    • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Genomic Data Analysis
      • 5.2.1.2.2. Proteomic Data Analysis
      • 5.2.1.2.3. Variant Data Analysis
    • 5.2.1.3. Drug Discovery Services
    • 5.2.1.4. Differential Gene Expression Analysis
    • 5.2.1.5. Database Management Services
    • 5.2.1.6. Others
  • 5.2.2. By Application
    • 5.2.2.1. Genomics
    • 5.2.2.2. Proteomics
    • 5.2.2.3. Chemoinformatics and Drug Design
    • 5.2.2.4. Pharmacogenomics
    • 5.2.2.5. Transcriptomics
    • 5.2.2.6. Metabolomics
    • 5.2.2.7. Others
  • 5.2.3. By Specialty
    • 5.2.3.1. Medical Biotechnology
    • 5.2.3.2. Animal Biotechnology
    • 5.2.3.3. Forensic Biotechnology
    • 5.2.3.4. Plant Biotechnology
    • 5.2.3.5. Environmental Biotechnology
  • 5.2.4. By End-user
    • 5.2.4.1. Academic Institutes and Research Centers
    • 5.2.4.2. Hospitals and Clinics
    • 5.2.4.3. Pharmaceutical and Biotechnology Companies
    • 5.2.4.4. Contract Research Organizations (CROs)
    • 5.2.4.5. Others
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Bioinformatics Services Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Type
        • 5.3.1.2.1.1. Sequencing Services
        • 5.3.1.2.1.1.1. Exome Analysis
        • 5.3.1.2.1.1.2. Transcriptome Analysis
        • 5.3.1.2.1.1.3. Metagenomic Analysis
        • 5.3.1.2.1.1.4. Other Services
        • 5.3.1.2.1.2. Data Analysis
        • 5.3.1.2.1.2.1. Genomic Data Analysis
        • 5.3.1.2.1.2.2. Proteomic Data Analysis
        • 5.3.1.2.1.2.3. Variant Data Analysis
        • 5.3.1.2.1.3. Drug Discovery Services
        • 5.3.1.2.1.4. Differential Gene Expression Analysis
        • 5.3.1.2.1.5. Database Management Services
        • 5.3.1.2.1.6. Others
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Genomics
        • 5.3.1.2.2.2. Proteomics
        • 5.3.1.2.2.3. Chemoinformatics and Drug Design
        • 5.3.1.2.2.4. Pharmacogenomics
        • 5.3.1.2.2.5. Transcriptomics
        • 5.3.1.2.2.6. Metabolomics
        • 5.3.1.2.2.7. Others
      • 5.3.1.2.3. By Specialty
        • 5.3.1.2.3.1. Medical Biotechnology
        • 5.3.1.2.3.2. Animal Biotechnology
        • 5.3.1.2.3.3. Forensic Biotechnology
        • 5.3.1.2.3.4. Plant Biotechnology
        • 5.3.1.2.3.5. Environmental Biotechnology
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Academic Institutes and Research Centers
        • 5.3.1.2.4.2. Hospitals and Clinics
        • 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
        • 5.3.1.2.4.4. Contract Research Organizations (CROs)
        • 5.3.1.2.4.5. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Bioinformatics Services Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Bioinformatics Services Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Bioinformatics Services Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Bioinformatics Services Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

• 14.1. Market Drivers
• 14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

• 16.1. Developments and Innovations
• 16.2. Regulatory Approvals

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Agilent Technologies, Inc.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. Thermo Fisher Scientific Inc.
  • 19.3.3. CD Genomics
  • 19.3.4. PerkinElmer AES
  • 19.3.5. Fios Genomics Ltd
  • 19.3.6. QIAGEN N.V.
  • 19.3.7. Source BioScience Limited
  • 19.3.8. Biomax GmbH
  • 19.3.9. Illumina, Inc.
  • 19.3.10. BGI Group

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer